Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman diseaseGaurav Goyal, Ronald S. Go, Karen L. Rech et al.|Haematologica|2019Cited by 215
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparitiesSikander Ailawadhi, Asher Chanan‐Khan, Ryan D. Frank et al.|Cancer|2018Cited by 55
Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age ReportingThejus Jayakrishnan, Sikander Ailawadhi, Sonikpreet Aulakh et al.|Cancers|2021Cited by 20
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparitiesSikander Ailawadhi, Asher Chanan‐Khan, Yaw Adu et al.|Blood Cancer Journal|2024Cited by 8
Patient Awareness of CAR-T and Bispecific Antibody Treatments for Multiple Myeloma: Real-World Learnings and DisparitiesYaw Adu, Sikander Ailawadhi, Saurav Das et al.|Blood|2023Cited by 3